We continue to fund the Managed Alcohol Programme pilot in Glasgow being run by Simon Community Scotland. We await the evaluation of the pilot being undertaken by the University of Stirling before reaching a position on future expansion.

The MAP pilot itself does not contribute directly to work being done to address alcohol-related brain damage, as those impacted by ARBD are referred elsewhere. NHS Greater Glasgow and Clyde does offer ARBD supported accommodation through Penumbra.

The Scottish Government supports Health and Social Care Partnerships with funding provided to Health Boards and local authorities to implement guidance, such as that published by the Mental Welfare Commission on alcohol-related brain damage.

That will be supplemented soon by the UK’s first comprehensive guidance for clinical treatment for alcohol conditions. The guidance will include requirements for the treatment of ARBD and we will support the adoption of the clinical guidance.

We recognise that the management and support required for people with ARBD is not limited to healthcare. Whether it is social care, mental health support, primary care or alcohol treatment and support - including rehabilitation - in communities or in residential settings, the person affected must be at the centre of the support pathway.

The Scottish Government has committed in our Cross Government Plan for tackling substance use harms to publishing a National Specification for alcohol and drug treatment and support services.

The Specification will include advice and requirements for local areas to make the public and people impacted by alcohol aware of the full range of services available, including for ARBD.

Since 2019, the Scottish Government has been supporting the sport sector to offer free period products; reducing stigma and addressing overarching gender equality.

I refer the member to the answer to question S6W-30734 on 11 November 2024. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

In addition to the information provided in answer S6W-30734, sportscotland’s Working with Female Athletes learning platform on Brightspace has recently been updated to include additional e-learning resources. This includes Sport Wales’ e-learning module on the menstrual cycle in sport. Resources are available for all and are free of charge.

While the Scottish Government sets the strategic policy for the NHS in Scotland, it is NHS Boards and healthcare professionals locally who have responsibility for both service delivery and ensuring people receive the right care for them, taking into account relevant guidance, local service needs and priorities for investment.

It is therefore for NHS Boards to determine what clinical interventions they offer, while giving regard to the considerations above.

The majority of Scottish health boards participated in the 2022 UK Parkinson’s Audit which measures the quality of Parkinson’s services against international best practice. This includes Patient Reported Experience Measure (PREM) data from people who use Parkinson’s services.

The 2022 Audit showed Scotland outperforming the UK in terms of future care planning, and access to essential professionals such as physiotherapists, occupational therapists and speech and language therapists.

The Scottish Medicines Consortium (SMC) appraises newly licensed medicines for clinical and cost-effectiveness to help Health Boards determine whether a medicine should be accepted for routine use within the NHS in Scotland. Following the appraisal process, the SMC publishes advice for Health Boards in Scotland to consider. The SMC does not issue tailored guidance for specific medicines.

Through the actions in our Women’s Health Plan we have taken steps to support both women and health professionals to learn more about endometriosis, the symptoms and treatment options, so that waiting times for diagnosis can improve.

This includes the development of an Endometriosis Care Pathway for NHS Scotland; funding the development of educational resources for healthcare professionals and our Women’s Health Platform on NHS Inform which aims to provide women with the information and tools they need to make informed decisions about their health.

The Women’s Health Plan highlights the need to improve the data on women’s health. That is why we published the Women’s Health Plan Data Landscape Review in November 2024. Improving data on women’s health and on endometriosis will continue to be a priority as we develop the next phase of the Women’s Health Plan.

Information about the progress to date against each of the priorities in the Women’s Health Plan can be found in the Women’s Health Plan Final Report.

In 2024-25, we allocated over £450,000 to gynaecology from our £30 million targeted investment in planned care, delivering around 3,500 additional new outpatient appointments.

The 2025-26 Budget will provide a record £21.7 billion for Health & Social Care, including a commitment to provide £200 million to help reduce waiting times and improve capacity, and gynaecology is being targeted as a key priority area for additional funding.

Our Women’s Health Champion, Professor Anna Glasier, and I have been meeting with clinicians to better understand the challenges that currently exist within gynaecology services, to discuss innovative solutions, and to reiterate our commitment that timely access to gynaecology services is a key priority area for the Scottish Government and for the next phase of the Women’s Health Plan.

Furthermore, the Scottish Government commissioned Centre for Sustainable Delivery (CfSD) has developed a strong clinically-led Specialty Delivery Groups (SDG) for Gynaecology, which promotes multidisciplinary team working and supports local adoption of service improvement programmes. This group has supported several new and innovative pathway developments, many of which are now being successfully scaled up across Scotland, including Active Clinical Referral Triage (ACRT) and Patient Initiated Review (PIR).

The Scottish Government has commissioned Healthcare Improvement Scotland to develop a set of maternity standards, designed to drive improvements in care at a local level and support consistency of service design and delivery across Scotland. This process has started, and we expect the standards to be completed in late 2025.

In addition, we welcomed the announcement from Healthcare Improvement Scotland in 2024 that they would initiate inspections of maternity services as part of the Safe Care Inspection process. These inspections started in late January 2025.

Our Best Start programme described a range of measures to improve care, the vast majority of which are now in place. We continue to work closely with NHS Boards, clinical leaders, the third sector and national partners to share learning, respond to emerging evidence and identify opportunities for continuous improvement at the national level.

The Scottish Government is committed to increasing the availability of safe and effective medicines that people in Scotland would benefit from. The Scottish Medicines Consortium (SMC) assesses the clinical and cost effectiveness of newly licensed medicines on a once for Scotland basis and publishes advice for Health Boards to consider. It is expected that Health Board Area & Drug and Therapeutics Committees (ADTCs) will consider making a SMC recommended medicine, or an equivalent, available on their local or regional formulary for routine prescribing within 90 days of SMC advice being published.

Health Boards are expected to apply common principles and processes in the introduction of newly licensed medicines to facilitate consistency of approach to local decision-making. The decision to prescribe a medicine, and which medicine to prescribe, is entirely for the clinician in charge of a person’s care, having considered their clinical condition, their safety, and any relevant clinical guidance.